Efficacy and Safety of Slenyto for Insomnia in Children With ASD

NCT04233502 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was not initiated it was decided to cancel this study

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Melatonin
DRUG: Placebo

Sponsor

Neurim Pharmaceuticals Ltd.